3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma KDA

KDA Group Inc.

KDA TSXV Biotech & Pharma

Stock factsheet

TickerKDA
ExchangeTSXV
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 12 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

KDA Group is a leader in technological innovations and specialized software solutions (SaaS - Software as a service) for the healthcare professionals' market. KDA is a corporation that offers quality products and has respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the healthcare's digital transformation, and are available for the Canadian and international markets.

Company description as published by the issuer via TMX Money.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
KDA Group Inc.KDA TSXV12 Mio. USD
Avicanna Inc. AVCNTSX 12 Mio. USD
Pharmala Biotech Holdings Inc. MDMACSE 12 Mio. USD
VVT Med Inc. VVTMTSXV 11 Mio. USD
Pharmacielo Ltd. PCLOTSXV 11 Mio. USD
Izotropic Corporation IZOCSE 12 Mio. USD
Nanalysis Scientific Corp. NSCITSXV 12 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.